• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有阴性免疫固定电泳和正常游离轻链比值的进展性孤立轻链淀粉样变心肌病。

Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio.

机构信息

Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, A-8036, Austria.

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.

出版信息

ESC Heart Fail. 2021 Aug;8(4):3397-3402. doi: 10.1002/ehf2.13381. Epub 2021 May 7.

DOI:10.1002/ehf2.13381
PMID:33960730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8318415/
Abstract

Amyloid light chain (AL) cardiomyopathy is the most malignant specific cardiomyopathy. According to international recommendations, it should be ruled out non-invasively using the serum free light chain (FLC) ratio and immunofixation electrophoresis in both serum and urine. Here, we report on a 69-year-old female patient with new-onset heart failure with mid-range ejection fraction. Cardiac imaging was highly suggestive of cardiac amyloidosis. Amyloid scintigraphy showed faint myocardial tracer uptake according to Perugini Score 1, but immunofixation was negative and the FLC ratio was normal, despite a slight increase in lambda FLCs. Endomyocardial biopsy revealed advanced myocardial lambda immunoglobulin light chain deposition. Clinically relevant extracardiac amyloid organ infiltration could not be detected. Conclusively, non-invasive testing can in rare cases fail to exclude isolated AL amyloid cardiomyopathy. We suggest that even slight increases in serum lambda or kappa FLCs should be considered abnormal in suspected cardiac amyloidosis if non-invasive testing delivers discrepant results.

摘要

轻链淀粉样变心肌病是最恶性的特异性心肌病。根据国际建议,应使用血清游离轻链(FLC)比值以及血清和尿液中的免疫固定电泳来进行非侵入性排除。在此,我们报告了一位 69 岁女性新诊断的心力衰竭伴中等射血分数患者。心脏影像学高度提示心脏淀粉样变性。根据 Perugini 评分 1,淀粉样闪烁扫描显示心肌示踪剂摄取微弱,但免疫固定电泳为阴性,FLC 比值正常,尽管 lambda FLC 略有增加。心内膜心肌活检显示晚期心肌 lambda 免疫球蛋白轻链沉积。临床相关的心脏外器官淀粉样浸润未被检测到。总之,在罕见情况下,非侵入性检查可能无法排除孤立的 AL 淀粉样变心肌病。我们建议,如果非侵入性检查结果不一致,即使血清 lambda 或 kappa FLC 略有增加,也应被视为可疑心脏淀粉样变性中的异常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/093b/8318415/240b9e5f3e06/EHF2-8-3397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/093b/8318415/3d5fc4851df0/EHF2-8-3397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/093b/8318415/c491479d8406/EHF2-8-3397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/093b/8318415/240b9e5f3e06/EHF2-8-3397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/093b/8318415/3d5fc4851df0/EHF2-8-3397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/093b/8318415/c491479d8406/EHF2-8-3397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/093b/8318415/240b9e5f3e06/EHF2-8-3397-g003.jpg

相似文献

1
Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio.伴有阴性免疫固定电泳和正常游离轻链比值的进展性孤立轻链淀粉样变心肌病。
ESC Heart Fail. 2021 Aug;8(4):3397-3402. doi: 10.1002/ehf2.13381. Epub 2021 May 7.
2
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.游离κ和游离λ免疫球蛋白轻链的血清参考区间及诊断范围:检测单克隆轻链的相对敏感性
Clin Chem. 2002 Sep;48(9):1437-44.
3
A patient with AL amyloidosis with negative free light chain results.一位有 AL 淀粉样变性且游离轻链检测结果为阴性的患者。
Clin Chem Lab Med. 2016 Jun 1;54(6):1035-7. doi: 10.1515/cclm-2015-0847.
4
Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.在 AL 淀粉样变性中单克隆无血清轻链二聚体和组织沉积轻链的氨基酸序列同源性:一项初步研究。
Clin Chem Lab Med. 2023 Sep 26;62(3):464-471. doi: 10.1515/cclm-2023-0591. Print 2024 Feb 26.
5
Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine.淀粉样变性轻链的鉴定需要将血清游离轻链检测与血清和尿液免疫固定相结合。
Clin Chem. 2009 Mar;55(3):499-504. doi: 10.1373/clinchem.2008.117143. Epub 2009 Jan 8.
6
False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report.心脏淀粉样变性轻链患者锝-99m 焦磷酸盐闪烁显像阳性:病例报告。
Medicine (Baltimore). 2021 Apr 30;100(17):e25582. doi: 10.1097/MD.0000000000025582.
7
A Case of Wild-type Cardiac Transthyretin Amyloidosis Diagnosed by Non-invasive Methods.一例通过非侵入性方法诊断的野生型心脏转甲状腺素蛋白淀粉样变性病例。
Curr Med Imaging. 2023;19(4):402-406. doi: 10.2174/1573405618666220610091446.
8
Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.用于心脏淀粉样变性亚分类的血清游离轻链分析的优化
J Cardiovasc Transl Res. 2015 Jun;8(4):264-8. doi: 10.1007/s12265-015-9628-2. Epub 2015 Apr 30.
9
Relationship between monoclonal gammopathy and cardiac amyloid type.单克隆丙种球蛋白血症与心脏淀粉样变性的关系。
Cardiovasc Pathol. 2013 May-Jun;22(3):189-94. doi: 10.1016/j.carpath.2012.09.001. Epub 2012 Oct 24.
10
Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.强转甲状腺素蛋白免疫染色:心脏淀粉样变性分型的潜在陷阱。
Am J Surg Pathol. 2011 Nov;35(11):1685-90. doi: 10.1097/PAS.0b013e3182263d74.

引用本文的文献

1
Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis-A Retrospective Austrian Multicenter Study.骨闪烁扫描术对心脏转甲状腺素蛋白淀粉样变性组织病理学诊断的诊断准确性——一项奥地利多中心回顾性研究
Biomedicines. 2022 Nov 28;10(12):3052. doi: 10.3390/biomedicines10123052.

本文引用的文献

1
Heart failure from ATTRwt amyloid cardiomyopathy is associated with poor prognosis.转甲状腺素蛋白野生型淀粉样心肌病所致的心力衰竭与预后不良相关。
ESC Heart Fail. 2020 Dec;7(6):3919-3928. doi: 10.1002/ehf2.12986. Epub 2020 Oct 1.
2
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.锝-99m 标记骨靶向示踪剂心肌闪烁显像用于疑似淀粉样变性:美国心脏病学会评论期刊本周专题。
J Am Coll Cardiol. 2020 Jun 9;75(22):2851-2862. doi: 10.1016/j.jacc.2020.04.022.
3
Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment.
免疫球蛋白轻链淀粉样变性:诊断、预后和治疗的 2020 年更新。
Am J Hematol. 2020 Jul;95(7):848-860. doi: 10.1002/ajh.25819. Epub 2020 Apr 28.
4
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease.κ/λ 游离轻链比的肾范围:评估慢性肾脏病患者多发性骨髓瘤的最佳策略。
BMC Nephrol. 2020 Mar 31;21(1):111. doi: 10.1186/s12882-020-01771-3.
5
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis.一项在既往治疗的系统性轻链淀粉样变性患者中应用达雷妥尤单抗的前瞻性 2 期临床试验。
Blood. 2020 Apr 30;135(18):1531-1540. doi: 10.1182/blood.2019004369.
6
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.专家共识建议:疑似转甲状腺素蛋白心脏淀粉样变性的诊断。
Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4.
7
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
8
Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.心脏淀粉样变性的发病机制与治疗进展
Curr Med Chem. 2019;26(16):2865-2878. doi: 10.2174/0929867325666180104153338.
9
Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters.心脏淀粉样变性鉴别诊断中的超声心动图参数:变形参数与非变形参数的直接比较
Circ Cardiovasc Imaging. 2017 Mar;10(3):e005588. doi: 10.1161/CIRCIMAGING.116.005588.
10
Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.疑似心脏淀粉样变性患者心血管磁共振成像的诊断准确性:一项系统评价和荟萃分析
BMC Cardiovasc Disord. 2016 Jun 7;16:129. doi: 10.1186/s12872-016-0311-6.